Related Experiment Video
Updated: Aug 8, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Genetic variation in genes of folate metabolism and neural-tube defect risk
Ivon J M van der Linden1, Lydia A Afman, Sandra G Heil
1Laboratory of Pediatrics and Neurology, Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Insights
Folic acid prevents neural-tube defects (NTD). Genetic variations in folate and homocysteine metabolism genes are linked to NTD risk, highlighting the importance of these genetic factors.
Area of Science:
- Genetics
- Biochemistry
- Public Health
Background:
- Neural-tube defects (NTD) are significant congenital malformations.
- Periconceptional folic acid intake prevents 50-70% of NTD cases.
- Genetic factors, like MTHFR C677T polymorphism, influence NTD risk.
Purpose of the Study:
- To review genetic variations in folate and homocysteine metabolism.
- To discuss the role of these variations in NTD risk.
Main Methods:
- Literature review of genetic polymorphisms.
- Analysis of enzymes in folate and homocysteine pathways.
- Summary of single-nucleotide polymorphisms (SNPs) and their association with NTD.
Main Results:
- Identified key SNPs in genes for folate transport, uptake, and metabolism.
- Highlighted the association between genetic variations and elevated homocysteine levels.
- Emphasized the link between these genetic factors and NTD susceptibility.
Conclusions:
- Genetic variations in folate and homocysteine metabolism pathways are crucial for NTD risk.
- Understanding these genetic factors can inform prevention strategies.
- Further research into genetic influences on NTD is warranted.
Abstract:
Neural-tube defects (NTD) are common congenital malformations that can lead to severe disability or even death. Periconceptional supplementation with the B-vitamin folic acid has been demonstrated to prevent 50-70% of NTD cases. Since the identification of the first genetic risk factor of NTD, the C677T single-nucleotide polymorphism (SNP) in the methylenetetrahydrofolate reductase (MTHFR) gene, and the observation that elevated plasma homocysteine levels are associated with NTD, research has focused on genetic variation in genes encoding for enzymes of folate metabolism and the closely-related homocysteine metabolism. In the present review relevant SNP in genes that code for enzymes involved in folate transport and uptake, the folate cycles and homocysteine metabolism are summarised and the importance of these SNP discussed in relation to NTD risk.
More Related Videos
03:19Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
Related Concept Videos
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Principles of Pharmacogenetics: Types of Genetic Variants
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genetic Variation
Genes exist in different versions called alleles, which...
Incomplete Dominance